Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Lincoln Pharmaceuticals Ltd

NSE: LINCOLN · BSE: 531633 · Pharmaceuticals & Biotechnology · 15 announcements

Share price
₹563.85
Market cap
₹1,129 Cr
Revenue (annual)
₹671.0 Cr
Net profit (annual)
₹87.89 Cr
P/E (TTM)
11.7×Sector 47.3×
Promoter holding
49.78%+0.00% QoQ
FII holding
4.60%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

12:37 IST BSE
Board Meeting Date

Lincoln Pharmaceuticals Board Meeting Date

Lincoln Pharmaceuticals Ltd will hold a board meeting on August 13, 2026. The board will consider and approve unaudited financial results for the quarter ended June 2026.